Oxurion Launches eTMF Module on Its Exagis Platform Following Adoption by Pierre Fabre
Oxurion has announced the commercial launch of the electronic Trial Master File (eTMF) module of its Exagis platform, developed by its subsidiary Axiodis. This new software component is part of the Belgian biotech's long-term strategy to build a comprehensive and modular eClinical platform for clinical trials.
A Key Module for Clinical Trial Data Management
The eTMF serves as a secure digital repository centralizing all essential documentation of a clinical trial. According to Oxurion, this component ensures regulatory compliance, prepares for inspections, and facilitates collaboration among stakeholders throughout the study lifecycle. The module extends the Exagis platform into an eClinical environment designed to simplify clinical trial operations, enhance operational efficiency, and strengthen regulatory oversight.
A Platform Developed by Practitioners for Practitioners
Exagis was developed within Axiodis CRO, a subsidiary of Oxurion, leveraging years of experience in conducting clinical trials. The platform combines operational expertise, ergonomics, and regulatory compliance. This integration of software development and operational execution allows Oxurion to continuously improve the solution to meet the evolving needs of sponsors and clinical research teams. The launch of the eTMF module marks a new milestone in Oxurion's long-term software strategy to progressively build a complete eClinical platform.
Progressing Towards a Complete eClinical Platform
Oxurion views this launch as a new step in its long-term software strategy aimed at gradually building a complete eClinical platform. The group indicates that future developments of the module should enhance the offering. According to Oxurion, each successive module increases the intrinsic value of the platform, strengthens customer engagement, and expands opportunities for recurring software revenue.
